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score of hemophilia (FISH);
Cartilage oligomeric matrix
protein (COMP)Abstract Aim of the work: The objective of our study was to determine the utility of serum
cartilage oligomeric matrix protein (COMP) as a serum biomarker for hemophilic arthropathy
and to evaluate the degree of joint damage radiologically using plain X-ray and functionally using
functional independence score of hemophilia (FISH) and to study their relation with COMP.
Patients and methods: The study was carried out on 30 boys with hemophilic arthropathy (group
I) and 20 healthy boys as control (group II). All hemophiliacs patients were scored for FISH and
radiological changes (Pettersson’s score). Factor activity level was measured in group I while
COMP was measured in both groups.
Results: The patients’ age ranged from 6 to 16 years (mean 10.6 ± 2.7 years). The knee was the
most commonly affected joint (83.3%). Fifteen patients (50%) had severe hemophilia, 7 had
moderate and 8 had mild hemophilia. Mean serum levels of COMP in hemophilic patients
(529 ± 288.1 ng/ml) were significantly higher than in control (285 ± 63.2 ng/ml) (p= 0.014).
The COMP level was significantly higher in patients with severe hemophilia compared to those with
moderate or mild disease (p< 0.001). The serum COMP significantly correlated with joint space
narrowing (r= 0.64, p< 0.001) and with the total Pettersson score (r= 0.42, p= 0.02) and
negatively with the FISH score (r= 0.44, p= 0.016).
Conclusions: Serum COMP level is indicative of the amount of joint damage in patients with
hemophilic arthropathy. The combined scoring of functional independence and Pettersson score
in addition to serum levels of COMP give a good overview of the degree of hemophilic arthropathy.
 2015 The Authors. Publishing services provided by Elsevier B.V. on behalf of Egyptian Society of
Rheumatic Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).iversity,
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Hemophilic arthropathy is a common complication of fre-
quent joint bleeding in patients with hemophilia [1]. Repeated
joint bleeding leads to synovial hypertrophy and hemosiderin
deposition. Synovitis occurs as a result of iron deposition,
which is associated with the release of cytokines. Recurrent
synovitis leads to the progressive destruction of the cartilage
and subchondral bone, resulting in joint space narrowing.
End-stage joint destruction, angulation, or ankylosis may
finally occur [2].
Cartilage oligomeric matrix protein (COMP) is also known
as thrombospondin [3,4]. COMP has a structural role in endo-
chondral ossification and in the assembly and stabilization of
the extracellular matrix by its interaction with collagen fibrils
and matrix components. COMP affects the fibril formation
of collagens I and II by promoting the early association of col-
lagen molecules which leads to accelerating fibrillogenesis with
a distinct organization of the fibrils [5]. It has also been shown
that COMP binds to aggrecan, a major component of the
cartilage extracellular matrix [6]. COMP is considered a mar-
ker of cartilage breakdown, and is being studied as a biological
marker in various uses [7].
COMP has been shown to be diagnostic of arthritis and to
correlate with the disease severity. In patients with various
types of arthritis, as rheumatoid arthritis (RA), reactive arthri-
tis, juvenile chronic arthritis, osteoarthritis COMP levels were
detected in all fluids, but were ten times higher in synovial fluid
than in serum indicating preferential release from the affected
joints [7]. The serum COMP level can be an important marker
of disease activity and cartilage destruction in systemic lupus
erythematosus (SLE) and osteoarthritis (OA) patients and
can be used as a parameter for monitoring the therapy
response [8]. The COMP level may become a nonspecific but
useful marker for joint involvement in systemic sclerosis
patients to identify patients at risk of joint damage and
developing subclinical RA overlap [9].
The objective of our study was to determine the utility of
COMP as a serum biomarker for hemophilic arthropathy and
to evaluate the degree of joint damage radiologically using plain
X-ray and functionally using Functional independence score of
hemophilia (FISH) and study their relation with COMP.
2. Patients and methods
2.1. Study population
The study was carried out on fifty boys divided into two
groups:
Group I: included 30 boys with hemophilia, with a history of
previous joint bleed. They were attending the Outpatient Hema-
tology Clinic and Physical Medicine, Rheumatology and Reha-
bilitation Clinic in Alexandria University Children’s Hospital at
Elshatby. All patients had at least one Target joint. ‘‘Target
joint” was defined as a joint with a history of clinical symptoms
of pain, tenderness, swelling or locking. Their age ranged from 6
to 16 years with a mean of 10.6 ± 2.7 years. Children having
any of the following were excluded from the study: Co-morbid
illness such as juvenile idiopathic arthritis, muscular dystrophy,
neuropathic arthropathy (that may obscure or confound the
hemophilia-based joint findings) and prior synovectomy.Group II: included 20 age-matched healthy boys without a
history of hemophilia as a control group. Their age ranged
from 5 to 14 years with a mean of 9.8 ± 2.7 years.
This study was explained to the participants and their
parents and an informed consent was taken from parents of
all participants included in the study. The study was approved
by local ethics committee of Alexandria University.
2.2. Assessment parameters
Each of the following were assessed in group I
– Functional independence score of hemophilia (FISH) [10]: It
includes the assessment of eight activities: eating, grooming,
dressing, chair transfer, squatting, walking, step climbing,
and running. Each activity is graded according to the amount
of assistance required to perform it. Each activity should be
scored only after observing the subject performing the task,
and not based on their subjective ability. For some of the tasks,
the required action may be simulated in the clinic and not actu-
ally performed. Each activity is graded from 1 to 4 according to
the amount of assistance required to perform the activity.
1 = unable or needs complete assistance to perform the activ-
ity; 2 = needs partial assistance/aids/modified instruments/-
modified environment to perform the activity; 3 = able to
perform the activity without aids or assistance, but with slight
discomfort. He is unable to perform the activity like his healthy
peers; 4 = able to perform the activity without any difficulty
like other healthy peers. The maximum possible score is 32.
– Conventional frontal and lateral radiographs of the most
affected joint were obtained. Scores were given to each joint
according to the Pettersson score by a radiologist [11,12]. In
the Pettersson system, the following 8 criteria are scored in
the most affected joint of each patient (Target joint): osteo-
porosis, enlarged epiphysis, irregular subchondral surface,
joint space narrowing (JSN), subchondral cyst formation,
erosions of the joint margins, gross incongruence of articulat-
ing bone ends, and deformity (angulation and/or displacement
between articulating bones). An item that has 2 sub-items, a
scale of 0–1 is used while items that have 3 sub-items a scale
of 0–2 (best to worst condition) is used. The maximum score
per joint is 13.
– Factor activity level was measured for all hemophilic
patients [13]: According to the degree of factor deficiency
patients were classified into 3 categories: severe hemophilia
(factor level < 0.01 IU/mL), moderate hemophilia (factor
level 0.01–0.05 IU/mL), mild hemophilia (factor level
> 0.05–0.4 IU/mL).
Level of cartilage oligomeric matrix protein (COMP)
analysis was determined with the use of commercially
available enzyme-linked immunosorbent assay (ELISA) a
sandwich-ELISA (AnaMar Medical, Lund, Sweden), and were
performed according to the manufacturers’ protocols for both
groups [14,15].
2.3. Statistical analysis
Data were fed to the computer using IBM SPSS software pack-
age version 20.0. Qualitative data were described using number
and percent. Quantitative data were described using mean and
standard deviation median, minimum and maximum. For
abnormally distributed data, Mann–Whitney test was used to
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for more than 2 populations. Correlations between two quan-
titative variables were assessed using Spearman coefficient.
Significance test results are quoted as two-tailed probabilities.
Significance was judged at the 5% level.
3. Results
The age was comparable between the hemophilic patients and
control (p= 0.59). Among the 30 hemophilic patients, 26
(86.7%) were hemophilia A and 4 (13.3%) hemophilia B.
The knee was the most commonly affected joint in 25
(83.3%) patients, followed by ankle in 4 (13.3%) patients
and elbow joint was most affected in only one (3.3%) patient.
Of the selected hemophiliacs, 15 (50%) had severe hemophilia,
7 (23.3%) had moderate and 8 (26.72%) had mild hemophilia.
The hemophilic patients had a significantly higher serum
COMP level (529 ± 288.1 ng/ml; median 512.5, min–max
100–1220 ng/ml) than the control (285 ± 63.2 ng/ml; median
297.5, min–max 155–375 ng/ml) (p= 0.014) (Fig. 1).
The serum COMP was significantly higher in patients with
severe hemophilia (757 ± 211.3 ng/ml; median 720, min–max
520–1120 ng/ml) compared to those with moderate (403.6
± 86.49 ng/ml, median 375, min–max 295–505 ng/ml) andmild
(211.25 ± 74.26 ng/ml, median 240, 100–290 ng/ml) hemophi-
lia (p< 0.001). Number of joints affected (during life) ranged
between 1 and 12 joints (median = 5 joints) and number ofFigure 1 Serum cartilage oligomeric matrix protein (COMP) in
hemophilic arthropathy patients and control.
Figure 2 Correlation of cartilage oligomeric matrix protein (COMP)
year in hemophilic patients.joint bleeds/year (last year) ranged between 1 and 40
(median = 10). A significant correlation was found between
serum COMP and number of joints affected (r= 0.49,
p= 0.006) and number of joint bleeds/year, (r= 0.82;
p< 0.001) (Fig. 2).
Pettersson score ranged from 0 to 7 (median = 1) in
hemophilic patients. Irregularity of subchondral surface
and joint space narrowing were the most common findings
(Table 1 and Fig. 3).
COMP significantly correlated with the joint space narrow-
ing score (r= 0.64, p< 0.001) and with the total Pettersson
score (r= 0.42, p = 0.02) (Fig. 4). The FISH score of hemo-
philic patients ranged from18 to 32 (mean = 26.97 ± 3).
Serum level of COMP showed significant correlation with
FISH score (r 0.44 and p= 0.016) (Fig. 5).
4. Discussion
Blood-induced arthropathy has pictures of degenerative joint
disease, as OA, and inflammatory joint disease, as RA [16].
Synovial tissue inflammation leads to cartilage destruction
[2,17,18] and independently of the synovial tissue, the blood
has direct adverse effects on cartilage [2,18]. Disturbance of
the turnover of proteoglycans and degradation of collagen
which are the main cartilage matrix components occur afterwith the number of joints affected and number of joint bleeds/last
Table 1 Characteristics of the Pettersson score among the
hemophilic patients.
Pettersson score items in hemophilic patients (n= 30) n (%)
Osteoporosis 4 (13.3)
Enlarged epiphysis 9 (30)
Irregular subchondral surface 10 (33.3)
Partially involved 8 (26.7)
Totally involved 2 (6.6)
Joint space narrowing 10 (33.3)
Joint space > 1 mm 7 (23.3)
Joint space 6 1 mm 3 (10)
Subchondral cyst formation (1 cyst) 5 (16.7)
Erosions of joint margins 7 (23.3)
Incongruence of articulating bone ends (slight) 3 (10)
Joint deformity 4 (13.3)
Slight 2 (6.6)
Pronounced 2 (6.6)
Figure 3 Radiological findings of the joints in hemophilic patients. A: knee joint with space narrowing (arrow), B: knee joint showing
subchondral bone cyst (arrow), C: elbow joint showing subchondral bone cyst (arrow) and osteoporosis (arrow head).
Figure 4 Correlation of cartilage oligomeric matrix protein (COMP) with the joint space narrowing and total Pettersson score in
hemophilic patients.
Figure 5 Correlation between serum level of cartilage oligomeric
matrix protein (COMP) and Functional independence score of
hemophilia (FISH) score in hemophilic patients.
244 H.M.A. Hassab et al.cartilage exposure to blood [19]. The relationship between
serum COMP levels and the amount of joint damage in
patients with hemophilic arthropathy has been previouslyexamined [20]. In this study the utility of COMP as a biomar-
ker for hemophilic arthropathy was determined and the degree
of joint damage radiologically using plain X-ray and function-
ally using FISH score was evaluated.
The serum COMP was significantly higher in hemophilic
patients compared to the control. It has been reported that a
single exposure to blood results in direct damage of joint
cartilage [20,21]. This may explain the significant correlation
between serum COMP and number of joint bleeds/year in
the current study. The pathogenesis of hemophilic arthropathy
starts with bleeding into the joint, cartilage degeneration,
synovial hypertrophy, limitation of joint movement with sub-
sequent limitation of function and release of the biomarker
secondary to cartilage degeneration.
Enlargement of epiphysis (30%) and irregular subchondral
surface (32%) were the most frequent observations while
osteoporosis was less observed (13.3%). This was supported
by the work of Erlemann et al. [22] which studied the degree
of osteoarthropathy in 40 hemophilic children using the
Pettersson score. On the other hand, a previous study by
Ghaniema et al. [23] on 20 male patients with hemophilia A,
their age ranged from 7 to 40 years, showed the presence of
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energy X-ray absorptiometry (DEXA). This was in accordance
with the study done by Wallny et al. who found a relationship
between hemophilia and osteoporosis [24]. This discordance
with the present study may be due to the older age group that
they used, second, this may owe to the limitation of the X-ray
to detect osteoporosis in comparison to the DEXA technique.
The significant correlation of serum COMP with the JSN score
has been supported by the study of Jansen et al. [20]. He stated
that JSN is the most important indicator of cartilage loss and
the most frequently reported parameter in evaluations of rela-
tionships between radiographic joint damage and cartilage
turnover biomarkers.
The present study showed a significant correlation
(r= 0.42, p= 0.02) between the total Pettersson score for
radiographic joint damage and serum COMP level, in
accordance with the results reported by Jansen et al. [20]
(r= 0.26, p= 0.06). This reflects the current processes of
cartilage degeneration and regulation, which indicates the
cumulative joint damage occurring overtime.
A significant negative correlation was present between the
FISH score and serum COMP determining the relation of
functional independence to cartilage turnover. No other stud-
ies correlated function with biomarkers in hemophilic
arthropathy, this issue needs to be investigated more. Among
the limitations of this study is the small number of patients
and control. Larger longitudinal studies are encouraged to
verify the present results.
In conclusion, serum COMP level is indicative of the
amount of joint damage in patients with hemophilic arthropa-
thy. The combined scoring of functional independence and
Pettersson in addition to serum levels of COMP gives a good
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